Cadila Healthcare informs about press release

17 Oct 2020 Evaluate

Cadila Healthcare has informed that it has enclosed a copy of press release dated October 17, 2020 titled ‘Zydus Cadila receives Final Approval from USFDA for Ursodiol Capsules and Tentative Approval for Linagliptin and Metformin Hydrochloride Tablets’.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

934.00 -25.55 (-2.66%)
24-Apr-2024 14:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1485.85
Dr. Reddys Lab 5936.90
Cipla 1397.65
Zydus Lifesciences 934.00
Lupin 1580.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.